.Observing an unsatisfactory revealing for Lykos Rehabs' MDMA applicant for post-traumatic stress di...
.AN2 Therapeutics is reassessing its company in feedback to poor midphase information, promising to ...
.Merck & Co. is paying out $700 thousand upfront to challenge Amgen in a blood stream cancer cell...
.Along With Gilead Sciences on the verge of an FDA choice for its own liver health condition drug se...
.CEO David Ricks can easily see the providers putting together camping tents at basecamp responsible...
.Mattress Liquidators has actually transformed Entero Therapies white colored as a piece. The collec...
.Exelixis is quiting on its tissue factor (TF)- targeting antibody-drug conjugate after ending the a...
.Three full weeks after Roche's Genentech unit walked away from an SHP2 prevention deal, Relay Rehab...
.Stoke Rehabs' Dravet syndrome medication has been without a predisposed grip, removing the techniqu...
.Fierce Biotech Associate Editor Gabrielle Masson offered the 2024 course of Ferocious 15 champions ...